Prospective development effective infusion regimens new antiarrhythmic drug study clinical pharmacology intravenous new antiarrhythmic drug Chinese herbal remedy first-study phase mg/kg minutes patients chronic nonsustained ventricular arrhythmias data infusions stable plasma concentrations infusions arrhythmias hours plasma concentrations ng/ml mean ng/ml SD QRS interval increases Mean clearance ml/min elimination half-life hours adverse effects study antiarrhythmic activity humans concentrations QRS rate-corrected QT studies patient populations dosages plasma concentrations clinical role dose-ranging approach safe initial evaluation patients 